Source:http://linkedlifedata.com/resource/pubmed/id/11765029
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2001-12-17
|
pubmed:abstractText |
2,6-Dimethylaniline (2,6-xylidine; 2,6-DMA) is a nasal carcinogen in rats. Humans may be exposed to this compound via several routes: 2,6-DMA is found in cigarette smoke; it is a pharmacologically inactive metabolite of some drugs (e.g., the local anesthetic lidocaine) and pesticides (e.g., metalaxyl); and it is an impurity in technical grade metalaxyl. The potential transfer of 2,6-DMA from mother to nursing infant via milk is of toxicological concern. Solid-phase microextraction with separation and detection using gas chromatography-mass spectrometry was optimized and used for the analysis of 2,6-DMA in milk. 2,6-DMA-d9 was synthesized and used for quantitation by the isotope ratio method. At a concentration of 5 ppb 2,6-DMA, the method detection limit was 0.20 ppb, and the relative standard deviation was 3.6%. Samples of milk were obtained from bovines administered lidocaine (2.9-3.9 mg/kg) during surgery. A breast milk sample was also obtained from a human donor who received 36 mg lidocaine during dental work. 2,6-DMA was present at levels ranging from 14.5 to 66.0 ppb in bovine milk and was detected at 1.6 ppb in the human milk sample. Our results demonstrate that 2,6-DMA, formed by the metabolism of lidocaine, is transferable to bovine and human milk.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2,6-xylidine,
http://linkedlifedata.com/resource/pubmed/chemical/Anesthetics, Local,
http://linkedlifedata.com/resource/pubmed/chemical/Aniline Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Carcinogens,
http://linkedlifedata.com/resource/pubmed/chemical/Lidocaine
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0146-4760
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
711-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11765029-Adult,
pubmed-meshheading:11765029-Anesthetics, Local,
pubmed-meshheading:11765029-Aniline Compounds,
pubmed-meshheading:11765029-Animals,
pubmed-meshheading:11765029-Breast Feeding,
pubmed-meshheading:11765029-Carcinogens,
pubmed-meshheading:11765029-Cattle,
pubmed-meshheading:11765029-Environmental Exposure,
pubmed-meshheading:11765029-Gas Chromatography-Mass Spectrometry,
pubmed-meshheading:11765029-Humans,
pubmed-meshheading:11765029-Infant,
pubmed-meshheading:11765029-Infant, Newborn,
pubmed-meshheading:11765029-Lidocaine,
pubmed-meshheading:11765029-Milk,
pubmed-meshheading:11765029-Milk, Human
|
pubmed:articleTitle |
Analysis of the lidocaine metabolite 2,6-dimethylaniline in bovine and human milk.
|
pubmed:affiliation |
Guelph-Waterloo Centre for Graduate Work in Chemistry, Department of Chemistry and Biochemistry, University of Guelph, Ontario, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|